Smoking and Weight: Simple Ways to Reduce MS Harm Now

Credibility

Interest

Share:2 min read

Key Takeaway

Stopping smoking and losing weight can lower immune signals that may make early MS worse, so lifestyle changes matter from the moment of diagnosis.

What They Found

The study looked at 96 people newly diagnosed with MS who were not yet on treatment and measured many immune signals in their blood. Smoking raised a molecule called GPR15 that helps immune cells travel into body tissues, and this was linked to more disability; you can think of it like opening more doors for immune cells to enter sensitive areas. Smokers also had higher levels of inflammation signals (for example, CXCL17 and LAMP3), which are chemicals that tell immune cells to act more aggressively. Higher possible sun exposure (UV) and vitamin D-related signals were tied to lower levels of some inflammatory genes (like IFI30 and LYZ), and one of those genes (IFI30) was linked to active brain lesions seen on MRI. Higher body weight (BMI) pushed certain blood cells (monocytes) to make more cholesterol-related products and inflammatory proteins (like FABP4 and LEP) that are tied to weakening the barrier that normally protects the brain from harmful blood substances.

Who Should Care and Why

People with MS should care because the study shows that things you can change—like smoking and body weight—are linked to immune changes that relate to disease activity, similar to how clearing clutter can make a room safer. Caregivers can use this information to support healthier habits early, which may help reduce immune signals that harm the brain and spinal cord. Clinicians may emphasize smoking cessation as a top priority because the study suggests quitting may be needed to stop certain harmful immune cell movements (like closing those ‘doors’ GPR15 opens). People who are overweight may benefit from even small, steady weight loss, because the study found a stepwise relationship—losing some pounds could lower inflammatory signals bit by bit. Everyone should see these as practical targets to discuss with their care team: quitting smoking, modest and steady weight loss, and safe sun exposure or vitamin D checks as part of early MS care planning.

Important Considerations

This study shows links but does not prove one thing directly causes another, so results should be seen as strong clues rather than absolute rules. The study used 96 patients from one center, so findings may not apply exactly the same to everyone with MS, especially those already on treatment or from different backgrounds. Also, some measurements (like sun exposure estimates) are indirect, so follow-up studies are needed before changing medical treatment plans based only on these results.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research MS Progression MS Genetics

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Neurology(R) neuroimmunology & neuroinflammation often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News